Published in Science · View the paper (DOI)
Researchers identified NUDT5 as a structural regulator that controls purine synthesis by physically restraining the key biosynthetic step. This mechanism may also explain cancer drug resistance and informs new therapeutic approaches for diseases caused by MTHFD1 deficiency.
Coverage from 2 institutions